Yondelis ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
159	色素性乾皮症	2

159. 色素性乾皮症

臨床試験数 : 11 / 薬物数 : 17 - (DrugBank : 5) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 15

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2010-022968-13-ES (EUCTR)	22/03/2011	25/01/2011	Estudio clínico de fase II, multicéntrico, abierto de trabectedina (Yondelis®) en pacientes con cánc ...	Estudio clínico de fase II, multicéntrico, abierto de trabectedina (Yondelis®) en pacientes con cánc ...	Cáncer de mama avanzado. MedDRA version: 13;Level: LLT;Classification code 10006204;Term: Carcinoma ...	Trade Name: YONDELIS0,25 mg polvo para concentrado para solución para perfusión INN or Proposed INN: ...	PharmaMar S.A. Sociedad Unipersonal	NULL	Not Recruiting			Female: yes Male: no	100	Phase 2	Belgium;Spain
2	EUCTR2010-022968-13-BE (EUCTR)	16/03/2011	04/01/2011	Study of the medicinal product Trabectedin in Patients with AdvancedBreast Carcinoma.	Multicenter, Open-Label, Phase II Study of Trabectedin (Yondelis®) in Patients with Hormonal Recepto ...	Advanced Breast Carcinoma MedDRA version: 14.0;Level: LLT;Classification code 10006204;Term: Breast ...	Trade Name: Yondelis0.25 mg powder for concentrate for solution for infusion. INN or Proposed INN: tr ...	Pharma Mar, S.A. Sociedad Unipersonal	NULL	Not Recruiting			Female: yes Male: yes	100	Phase 2	Spain;Belgium

First Previous1Next Last